Get started
Author

Elisabetta Balestro

Observed names: BALESTRO E, BALESTRO, ELISABETTA, Balestro, E, Balestro, E., Balestro, Elisabetta, E Balestro, E. Balestro, ELISABETTA BALESTRO
Observed institutions: University of Padua, Sanjay Gandhi Post Graduate Institute of Medical Sciences, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Ospedale Vincenzo Cervello, Azienda Ospedaliero-Universitaria delle Marche, Ospedale San Bassiano, Azienda Ospedale - Università Padova
ORCID: 0000-0003-1373-8197
Observed ORCID: 0000-0003-1373-8197
OpenAlex ID: A5006040570
Pulmonary fibrosis secondary to COVID-19: a call to arms?
2020 · Paolo Spagnolo, Elisabetta Balestro, et al. · The Lancet Respiratory Medicine · 481
PDF
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease
2008 · Fiorella Calabrese, Simonetta Baraldo, et al. · American Journal of Respiratory and Critical Care Medicine · 167
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity
2017 · Erica Bazzan, Graziella Turato, et al. · Respiratory Research · 155
PDF
Critical Review of the Evolution of Extracellular Vesicles’ Knowledge: From 1946 to Today
2021 · Erica Bazzan, Mariaenrica Tinè, et al. · International Journal of Molecular Sciences · 149
PDF
Low-volume ventilation causes peripheral airway injury and increased airway resistance in normal rabbits
2002 · Edgardo D'Angelo, Matteo Pecchiari, et al. · Journal of Applied Physiology · 142
Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
2016 · Elisabetta Balestro, Fiorella Calabrese, et al. · PLoS ONE · 98
PDF
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO)
2020 · Francesca Polverino, Debra A. Stern, et al. · Frontiers in Cardiovascular Medicine · 74
PDF
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease: B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family
2010 · Francesca Polverino, Simonetta Baraldo, et al. · American Journal of Respiratory and Critical Care Medicine · 73
Dependence of lung injury on inflation rate during low-volume ventilation in normal open-chest rabbits
2004 · Edgardo D'Angelo, Matteo Pecchiari, et al. · Journal of Applied Physiology · 72
Noneosinophilic asthma in children: relation with airway remodelling
2011 · S. Baraldo, G. Turato, et al. · European Respiratory Journal · 71
PDF
The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
2019 · Paolo Spagnolo, Philip L. Molyneaux, et al. · International Journal of Molecular Sciences · 70
PDF
Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art
2020 · Francesca Polverino, Elisabetta Balestro, et al. · Journal of Clinical Medicine · 69
PDF
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe
2022 · Theodoros Karampitsakos, Paolo Spagnolo, et al. · Respirology · 67
Immune Activation in α1-Antitrypsin-Deficiency Emphysema. Beyond the Protease–Antiprotease Paradigm
2014 · Simonetta Baraldo, Graziella Turato, et al. · American Journal of Respiratory and Critical Care Medicine · 66
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey
2019 · Catharina C. Moor, Marlies S. Wijsenbeek, et al. · ERJ Open Research · 61
PDF
Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
2013 · Fiorella Calabrese, Anja Kipar, et al. · PLoS ONE · 54
PDF
Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis
2021 · Nicol Bernardinello, Simone Petrarulo, et al. · Diagnostics · 51
PDF
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis
2018 · Sergio Harari, Antonella Caminati, et al. · Respiration · 50
PDF
Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients
2021 · Chiara Giraudo, Giovanni Librizzi, et al. · PLoS ONE · 48
PDF
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
2021 · Davide Biondini, Elisabetta Cocconcelli, et al. · Respiratory Research · 48
PDF
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
2022 · Paolo Spagnolo, Roberto Tonelli, et al. · Expert Opinion on Therapeutic Targets · 47
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
2021 · Meena Kalluri, Fabrizio Luppi, et al. · European Respiratory Review · 47
PDF
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
2023 · Elisabetta Zanatta, Elisabetta Cocconcelli, et al. · RMD Open · 45
PDF
Expression of the Atypical Chemokine Receptor D6 in Human Alveolar Macrophages in COPD
2013 · Erica Bazzan, Marina Saetta, et al. · CHEST Journal · 45
PDF
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies
2020 · Davide Biondini, Elisabetta Balestro, et al. · Expert Review of Respiratory Medicine · 43
Works count: 229
Citation count: 3,206
H-index: 29
I10-index: 63
Year
Topic
Type